MindLinc

MindLinc is a digital solution developed by Holmusk that aims to transform behavioral health research, innovation, and care. According to the vendor, MindLinc leverages real-world data and analytics to improve the understanding and treatment of behavioral health conditions. The platform is designed for organizations of various sizes, including academic or research institutions, CROs, life sciences, pharma, or biotech companies, providers, hospitals, health systems, payers, and other healthcare organizations. Professionals in the fields of behavioral health research, mental health and psychiatry, market access, medical affairs, and health economics and outcomes research can benefit from the features offered by MindLinc.

Key Features

NeuroBlu Database: According to the vendor, MindLinc's NeuroBlu Database captures and maps de-identified data from patient electronic health records across the U.S., creating a single source of truth for behavioral health care delivery.

Longitudinal Data: MindLinc follows patients over time with over 20 years of data, spanning inpatient and outpatient sites such as hospitals, emergency rooms, and community psychiatry clinics. This feature enables observational studies with curated and fit-for-purpose data, according to the vendor.

Comprehensive Outcome Measures: MindLinc tracks patient functioning and outcomes, allowing for comparisons between different groups of patients using standardized quantitative outcome measures. The platform provides composite scores and individual item responses for research purposes, as claimed by the vendor.

Behavioral Health Conditions: MindLinc covers a range of conditions including substance use disorders, major depressive disorder, bipolar disorder, attention-deficit/hyperactivity disorder, adjustment disorders, post-traumatic stress disorder, generalized anxiety disorder, schizophrenia, personality disorders, panic disorder, and conduct disorders, according to the vendor.

Behavioral Health Assessments: MindLinc provides composite scores and individual item responses for various assessments such as the Brief Bipolar Disorder Symptom Scale, Brief Negative Symptom Assessment, Clinical Global Impressions, Columbia-Suicide Severity Rating Scale, Global Assessment of Functioning, Patient Health Questionnaire-9, Positive Symptom Rating Scale, The Daily Living Activities–20, and The Quick Inventory of Depressive Symptomatology. These assessments aid in evaluating patients comprehensively, as stated by the vendor.

Pharmacological Treatments: MindLinc contains information on psychotherapy and pharmacologic treatments, including antidepressants, antipsychotics, anxiolytics, hypnotics and sedatives, mood stabilizers, psycholeptics, and psychostimulants, according to the vendor.

Enriched Data for Deeper Clinical Context: MindLinc applies natural language processing models to extract information from unstructured clinical notes, transforming it into standardized measures for more fit-for-purpose data. This feature adds valuable context to research by making additional data available, as claimed by the vendor.

Digital Solutions: MindLinc offers user-friendly data analytics software with no-code analytics capabilities. The platform provides pre-designed study templates for faster insights and allows for analysis within NeuroBlu alongside clinical and data science experts for customized support, according to the vendor.

Management and Supervision Tool (MaST): MindLinc's MaST is a clinical decision support tool that leverages data visualization and predictive analytics. It prioritizes individuals at risk of crisis, improves caseload management, and integrates measurement-based care with an electronic health record designed for data capture and visualization within mental health clinics, as claimed by the vendor.